ICTM logo
TRISST update

01 August 2008

TRISST is a randomised, phase III trial to assess whether a reduced CT schedule or MRI could be used as a safe and effective alternative to standard CT-based surveillance in the management of stage 1 seminoma testis without evidence of NSGCT elements.

This trial will help us determine the optimum post-operative monitoring schedule balancing the need to detect recurrences promptly with the wish to minimise patients’ exposure to radiation associated with diagnostic scans.

For further information about the trial please contact the TRISST trial team at trisst@ctu.mrc.ac.uk.